Comprehensive Oncology Care | Advanced Research | Compassionate Treatment
The foundation’s research and academic endeavors are deeply rooted in a multidisciplinary approach that integrates clinical expertise, translational science, and technological innovation. The department actively contributes to peer-reviewed publications spanning medical, surgical, and radiation oncology, with faculty and collaborators regularly publishing impactful studies in national and international journals. These works reflect a commitment to advancing knowledge, improving patient outcomes, and sharing evidence-based insights with the global oncology community.
• Year: 2025 • DOI: https://dx.doi.org/10.18203/2394-6040.ijcmph20252162
Predictive modelling of tumor response and progression in cervical and head and neck cancers: a retrospective and prospective validation study.
• Year: 2021 • DOI: https://dx.doi.org/10.18203/2394-6040.ijcmph20212585
Utility of augmented breast self-examination as an education and screening tool in Rural India for early detection of breast cancer
• Year: 2010 • DOI: 10.4103/0973-1482.77100
Risk-scoring system for predicting mucositis in patients of head and neck cancer receiving concurrent chemoradiotherapy [rssm-hn]
Learn More about Institution publications
Learn More about Institution publications
The foundation’s research philosophy centres on collaboration and innovation. In partnership with MedhAnkura, a healthcare R&D organization, and multiple technology-driven startups, several pioneering projects are underway to develop scalable, patient-centric solutions in cancer care and beyond. These initiatives combine scientific insight with real-world application to address the evolving challenges of oncology across diverse populations.
• Precision oncology, cellular therapy, and immuno‑oncology
• AI‑assisted triage, radiology‑pathology correlation, and outcome analytics
• Community screening effectiveness and survivorship quality metrics
These focus areas align with global efforts to strengthen early detection, precision treatment, and equitable access to cancer care principles that reflect the UICC’s broader mission to reduce disparities and advance global cancer control.
Several of the foundation’s research collaborations have resulted in patent filings and granted innovations that extend across oncology, maternal health, infectious diseases, and medical technology. These patents represent a commitment to developing real-world solutions that enhance diagnosis, treatment, and healthcare delivery through scientific rigor and innovation.
These innovations collectively represent an ecosystem of research that blends clinical science, technology, and implementation pathways to bring impactful change in healthcare delivery.
A system and method for generation and use of radiation outcome prediction score in patients undergoing radiotherapy
Granted (India, USA)
System and method for automated gross examination of tissues
Granted (India, USA, Europe)
Multi-Antigen Lateral Flow Immunoassay Device with AI-Driven Risk Assessment for Cancer and Inflammatory Conditions
Final Evaluation
AI-Driven Dual-Tracer PET Platform for Precision Theranostics in Metastatic Prostate Cance
Filed
Automatic Grossing System with Intelligent Pathology Reporting
Under Review
These innovations collectively represent an ecosystem of research that blends clinical science, technology, and implementation pathways to bring impactful change in healthcare delivery.
Other patents spanning innovations in health intelligence, infection detection, device automation, and digital process optimization
Various stages (Granted / Filed / Under Review)
The foundation continues to expand its research footprint through national and international collaborations, academic exchanges, and participation in scientific conferences. By aligning institutional goals with global oncology priorities, we aim to contribute meaningful evidence and scalable innovations that support early detection, equitable treatment access, and improved survivorship outcomes.
© 2025 Cancer Center